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We recently reported a direct echnique for determin- 
ing the binding sites of small molecules onnaturally oc- 
curring heterogeneous DNA (Van Dyke et al. 1982). 
Methidiumpropyl-EDTA.Fe(lI) (MPE.Fe[I~) (Hertzberg 
and Dervan 1982) cleaves double-helical DNA with low 
sequence-specificity (Van Dyke et al. 1982). Using a com- 
bination of MPE-Fe(II) partial cleavage of drug- 
protected DNA fragments and Maxam-Gilbert sequenc- 
ing methods, we determined the drug-protected sites on 
one strand of a double-helical fragment from pBR322 for 
the intercalator actinomycin D (Goldberg et al. 1962; 
Muller and Crothers 1968; Wells and Larson 1970; Sobell 
1973; Krugh 1981; Patel t al. 1981; Takusagawa et al. 
1982) and the minor-groove binders netropsin and 
distamycin A (Luck et al. 1974; Wartell t al. 1974; Zim- 
mer 1975; Berman et al. 1979; Krylov et al. 1979). 
Netropsin and distamycin A gave identical DNA-cleavage 
inhibition patterns or footprints in regions rich in dA.dT 
base pairs. Actinomycin D afforded a completely different 
footprint pattern centered a ound one or more dG.dC 
base pairs (Van Dyke et al. 1982). (See Fig. 1 for struc- 
tures of MPE.Fe[II], actinomycin D, and distafiaycin A.) 
We are not certain whether there is a one-to-one cor- 
respondence between a protected region on one strand 
of the double-helical DNA fragment and the drug- 
binding site on the DNA. We presume that the reaction 
responsible for DNA strand scission by MPE.Fe(II) is 
an oxidative cleavage of the deoxyribose ring analogous 
to mechanisms postulated for bleomycin activity (Hecht 
1979; Burger et al. 1981). The different accessibility of 
adjacent deoxyribose rings to the propyl-EDTA.Fe(II) 
moiety in the unprotected site bound by MPE might 
r sult in asymmetric footprints on opposite DNA 
strands. From model building with right-handed, 
double-helical DNA and MPE.Fe(II), we expect he 
footprint on each DNA strand to be shifted at least 1 bp 
to the 3' side of the drug-binding site (Fig. 2). Greater 
precision in identifying the boundaries of the preferred 
drug-binding sites would be afforded by an analysis of 
opposite strands. 
We report here complementary-strand analyses of 
distamycin and actinomycin binding on heterogeneous 
DNA using the MPE-Fe(II) footprinting technique. Two 
DNA restriction fragments, 117bp and 168 bp in length, 
each containing regions f identical sequence, were 
prepared with 3' -end labeling on complementary strands. 
DNA-cleavage inhibition patterns resulting from 
MPE.Fe(II) cleavage ofthe drug-protected DNA restric- 
tion fragments provide the opposite-strand footprints (Fig. 
3). This affords a more precise location f the preferred 
binding sites on 50 bp of heterogeneous DNA for 
distamycin and actinomycin. 
MATERIALS AND METHODS 
Actinomycin D was obtained from Merck, Sharpe, and 
Dohme. Distamycin A was obtained from Boehringer 
Mannheim. Dithiothreitol (DTT) was obtained from 
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Figure 1. Methidiumpropyl-EDTA'Fe(II), actinomycin, a d distamycin. 
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Figure 2. Model for asymmetric footprint. 
Calbiochem. Ferrous ammonium sulfate, Fe(NH4)2- 
(SO4h'6H20, was obtained from Baker. MPE was syn- 
thesized and purified by procedures already described 
(Hertzberg and Dervan 1982). The plasmid pLJ3, con- 
structed by L. Johnsrud (Harvard University), was a 
generous girl from D. Galas (University of California, 
Los Angeles). 
Solutions of Fe(NH4)2(SO4)2.6H20, DTT, and MPE 
were freshly prepared. Concentrations of MPE, ac- 
tinomycin, and distamycin were determined spectro- 
scopically. Reactions (10 #l final volume) contained 10 
mM Tris-HCl (pH 7.8) and 50 mM NaCl. Each reaction 
mixture contained more than 600 cpm of DNA labeled 
on the 3' end with 32p, and the final concentration of
DNA base pairs was brought up to 100 #M by the addi- 
tion of sonicated, deproteinated calf thymus DNA. 
When present, final concentrations were l0 #M MPE, 
l0 #M Fe(II), and 4 mM DTT. Actinomycin and dista- 
mycin concentrations were adjusted (l-100 #M) as 
specified in Figure 5. For footprinting, a solution of 
buffered DNA was incubated for 30 minutes at 20~ 
with either actinomycin or distamycin. The reaction was 
initiated by the addition of MPE-Fe(II) followed by 
DTT. The reaction was allowed to run at 37~ for 15 
minutes, stopped by freezing in dry ice, and then lyoph- 
ilized and resuspended in formamide loading buffer for 
gel electrophoresis (Maxam and Gilbert 1980). 
Preparation of specific, labeled DNA fragments. 
DNA for this investigation consisted of a sequenced seg- 
ment of the lactose operon in Escherichia coli. This was 
isolated from the plasmid pLJ3 grown in E. coli strain 
MM294. Part of this plasmid is a 285-bp insert contain- 
ing two copies of the lactose operon promoter-operator 
sequence in the same orientation. A schematic diagram 
of the insert is shown in Figure 3. Milligram quantities 
of the plasmid were isolated by procedures similar to 
those of Tanaka and Weisblum (1974). Superhelical 
pLJ3 plasmids were first digested with the restriction 
endonuclease EcoRI and then labeled on the 3' end with 
[32p]dATP and the Klenow fragment of DNA polymer- 
ase I. A second enzymatic digest with the restriction 
endonuclease HaeIII yielded two end-labeled fragments, 
117 bp and 168 bp in length. These were isolated by gel 
electrophoresis on a 5% polyacrylamide, 1:30 cross- 
linked, 4-mm-thick preparatory gel. Further recovery 
and purification followed procedures similar to those of 
Maxam and Gilbert (1980). 
Sequencing gels. Resolution of inhibition patterns 
was achieved by electrophoresis on8 % polyacrylamide, 
1"20 cross-linked sequencing els that were 0.4 mm 
thick, 40 cm long and contained 50% urea. Electro- 
phoresis was carried out at 1000 V for 3.5 hours to se- 
quence 100 nucleotides, beginning 20 nucleotides from 
the labeled 3' end. Autoradiography was carried out at 
-50~ without he use of an intensification screen. 
Densitometry. An 8 x 10-inch copy of the original 
autoradiograph was scanned at 485 nm with the incident 
beam collimated to a width of 0.05 mm on a Cary 219 
spectrophotometer. The data were recorded as absor- 
bance relative to the film-base density and analyzed 
using an Apple microcomputer. 
RESULTS 
For an investigation of the sequence-specific DNA- 
cleavage inhibition by actinomycin and distamycin with 
MPE.Fe(II), two DNA substrates were prepared. The 
117-bp and 168-bp restriction fragments, each contain- 
ing the lactose operon promoter-operator region, were 
prepared with the 3' ends labeled with 32p on com- 
plementary strands. MPE.Fe(II)/DTT was allowed to 
react with the 117-bp or 168-bp fragments alone (Fig. 4) 
and with the l l7-bp or 168-bp fragments pre- 
equilibrated with either actinomycin or distamycin (Fig. 
5). Partial cleavage by MPE.Fe(II) was stopped after 15 
minutes by freezing, lyophilization, and resuspension i  
formamide buffer. The s2p-end-labeled DNA products 
were analyzed by denaturing 8% polyacrylamide/50% 
urea gel electrophoresis, which is capable of resolving 
DNA fragments differing in length by one nucleotide. 
The autoradiographic data are shown in Figures 4 and 5. 
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Figure 3. Schematic diagram of 117-bp and 168-bp 
fragments derived from cleavage of 285-bp 3'-end- 
labeled fragment with the restriction enzyme 
HaeIII. The 117-bp and 168-bp fragments each con- 
tain one copy of the lactose operon promoter- 
operator region with complementary-strand, 3'-end 
labeling. 
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Figure 4. Autoradiograph of sequencing gel of MPE-induced cleavages of DNA. (Lanes 1-9) 117-bp DNA fragment. (Lane 1 ) (117-bp 
DNA standard; (lanes 2-5) reactions contained 200/~M DNA, 50 #M Fe(lI), 4.6 mM DTT, and MPE at 5, 10, 20, and 40 ttM; (lanes 6-9) 
Maxam-Gilbert sequencing reactions G, A >C, C, C +T, respectively. (Lanes 10-18) 168-bp DNA fragment; (lanes 10-13) Maxam-Gilbert 
sequencing reactions C +T, C, A >C, G, respectively; (lanes 14-17) reactions contained 200/~M DNA, 50 #M Fe(II), 4.6 mM DTT, and 
MPE at 5, 40, 20, 10 #M; (lane 18) 168-bp DNA standard. 
MPE.Fe(II) Cleaves DNA Uniformly 
Controls. Several control experiments in the ab- 
sence of inhibiting drugs were carried out. Lanes 1 and 
18 of Figure 4 are the buffered, intact l l7 -bp and 
168-bp DNA fragments (200/zM in base pairs). The two 
bands at the top of these control anes presumably arise 
from incomplete denaturation. Lanes 2-5 (117-bp frag- 
ment) and 14-17 (168-bp fragment) of Figure 4 contain 
200 #M DNA, 50 #M Fe(II), 4.6 mM DTT, 5-40 #M 
 Cold Spring Harbor Laboratory Press on May 5, 2016 - Published by symposium.cshlp.orgDownloaded from 
350 VAN DYKE AND DERVAN 
Figure 5. Autoradiograph of sequencing gel depicting footprints for actinomycin D and distamycin A. (Lanes 1-12) 117-bp DNA frag- 
ment. (Lane 1)117-bp DNA standard; (lanes 2-8) reactions contained 100/zm DNA, 10 flu Fe(II), l0/zu MPE, and 4 mM DTT; (lane 2) 
reaction with MPE'Fe(II) and no inhibition drugs; (lanes 3-5) reactions contained actinomycin D at l, 10, nd 100 #M; (lanes 6-8) reac- 
tions contained distamycin A at 1, 10, and 100/zu; (lanes 9-12) Maxam-Gilbert sequencing reactions G, A > C, C, C + T, respectively. 
(Lanes 13-24) 168-bp DNA fragments. (Lanes 13-16) Maxam-Gilbert sequencing reactions C +T, C, A >C, G, respectively; (lanes 
17-23) reactions contained I00/zu DNA, 10 ttu Fe(II), l0/zu MPE, 4 mu DTT; (lanes 17-19) reactions contained distamycin A at 100, 
10, and l re.i; (lanes 20-22) reactions contained actinomycin D at 100, 10, and 1/zM; (lane 23) reaction with MPE.Fe(II) and no inhibition 
drug; (lane 24) 168-bp DNA standard. 
MPE. Lanes 2-5 and 14-17 depict the relatively 
uniform cleavage pattern generated by MPE over a 
broad concentration range. This provides the baseline 
by which other cleavage patterns are compared. Lanes 
6-13 are the products of the Maxam-Gilbert sequencing 
reactions and are used as markers for base identifica- 
tion. 
Lanes 1 and 24 of Figure 5 are the buffered, intact 
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Figure 6. Densitometer scan (left to right) of llT-bp DNA frag- 
ment (from lower arrow to upper arrow on gel autoradiograph in 
Fig. 5. (Top) Lane 5, actinomycin at 100 /zM; (middle) lane 7, 
distamycin at 10/zM; (bottom) lane 1, MPE-Fe(II) control9 Valleys 
are regions protected by drugs from MPE.Fe(II) cleavage. 
117-bp and 168-bp DNA fragments, respectively (100 
#M in base pairs). Lanes 2 (117-bp fragment) and 23 
(168-bp fragment) are controls containing 100 ttM DNA, 
10 ttM MPE.Fe(II), and 4 mM DTT, indicating a uni- 
form cleavage pattern. 
Actinomycin. Different concentrations of actinomy- 
cin (1 #M, 10 ttM, and 100 /~M) were allowed to 
equilibrate with the 117-bp and 168-bp DNA fragments 
(100 #M bp). To this was added 10 #M MPE.Fe(II) and 
4 mM DTT (final concentrations). A series of bands or 
regions of alternating high and low density on the 
autoradiograph are observed when MPE.Fe(II)/DTT 
cleaves DNA in the presence of actinomycin. The 
highest concentration f actinomycin D (100 ttM) shows 
the sharpest footprinting patterns (Fig. 5, lanes 5 and 
20). The densitometer trace allows a measure of the ac- 
tinomycin blocking of MPE.Fe(II) DNA cleavage on a 
50-bp section of the ll7-bp and 168-bp restriction 
fragments (Figs. 6 and 7), which are illustrated as pro- 
tected regions on opposite strands in Figure 8. 
Distamycin. Different concentrations of distamycin 
(1 #M, 10/zM, and 100 ttM) were allowed to equilibrate 
with the 117-bp and 168-bp DNA fragments (100/~M 
r 
MPE 9 Fe(~l CONTROL 
Figure 7. Densitometer scan (left to right) of 168-bp DNA frag- 
ment (from lower arrow to upper arrow on gel autoradiograph in 
Fig. 5). (Top) Lane 20, actinomycin at 100 #M; (middle) lane 18, 
distamycin at l0 ttM; (bottom) lane 23, MPE,Fe(II) control. 
Valleys are regions protected by drugs from MPE'Fe(II) cleavage. 
bp). To this was added 10/LM MPE.Fe(II) and 4 mM 
DTT (final concentrations). Lower concentrations of 
distamycin (10/~M) were sufficient to produce footprints 
that are well resolved compared with the case of ac- 
tinomycin. Certain dA-dT-rich regions that suffered ef- 
ficient MPE.Fe(II) cleavage in the presence of ac- 
tinomycin are now protected by distamycin. Inspection 
of gel-lanes 5 and 7 of Figure 5 (actinomycin and dis- 
tamycin, respectively) reveals complementary regions 
(dG.dC vs. dA.dT rich), resulting from different pro- 
tection by the two drugs. 
DISCUSSION 
Complementary-strand Footprints 
In principle, an altered DNA-cleavage pattern could 
be the result of suppressed reaction at some sites, 
enhanced reaction at others, or a combination ofboth ef- 
fects. Without ruling out the possibility of enhanced 
cleavage, we have interpreted the light regions on the 
autoradiograph as regions of reduced cleavage of DNA 
Figure 8. Illustration of drug-protected regions 
(black areas) for actinomycin, opposite-strand 
analysis. (Top) 16g-bp fragment; (bottom) l l7-bp 
fragment. 
5'CTTTAGAGTTTATGCTTGGGGGTCGTATAATGTGTGGAATTGTGAGCGGA 3'* 
*3' GAAATGTGAAATACGAAGGCCGAGCATATTACACACCTTAACACTCGCCT 5' 
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A A Figure 9. Illustration of drug-protected regions 
(black areas) for distamycin, opposite-strand analy- 
sis. (Top) 168-bp fragment; (bottom) 117-bp frag- 
ment. 
by MPE.Fe(II) due to the presence of bound drug. The 
light regions on the autoradiograph (Fig. 5) correspond 
to the valleys in the densitometer tracings (Figs. 6 and 
7), which, in turn, correspond to the black regions on 
opposite strands on the 50-bp sequence shown in 
Figures 8 and 9. 
We can see from complementary-strand alysis that 
the footprints are asymmetric for both actinomycin and 
distamycin. The footprints appear to be shifted 1-2 bp 
to the 3' side on each strand and 1 bp underprotected on
the 5'  side. These data are consistent with the model 
(Fig. 2). With this knowledge, we can now interpret the 
footprint and assign the preferred binding sites of ac- 
tinomycin and distamycin with greater confidence. In 
addition, single-strand analyses of MPE footprinting of 
actinomycin and distamycin on other DNA restriction 
fragments become amenable to interpretation (Van 
Dyke et al. 1982). 
The 50-bp sequence that afforded the complementary- 
strand analysis is composed of 44% dG.dC and 56% 
dA.dT. We can identify 24 bp protected by the minor- 
groove binder distamycin out of 50 bp, which cor- 
responds to 48% saturation (Fig. 10). Of the 24 bp pro- 
tected by distamycin, 20 bp (83%) are dA.dT. The 
minimum protected region bserved is the 4-bp se- 
quence, 5'  AATT 3' .  For a binding-site size of 4 bp, 
the binding density (ligand bound/bp) would be 0.12 or 
six molecules on the 50-bp sequence. 
Similarly, we can identify 22 out of 50 bp protected 
by the intercalator actinomycin, which corresponds to 
44% saturation (Fig. 10). Of the 22 bp protected by ac- 
tinomycin, 15 bp (68%) are dG-dC. The minimum pro- 
tected region observed is the 3-bp sequence, 5' GTG 3' .  
For a binding-site size of 3 or 4 bp, the binding density 
for actinomycin would be 0.15-0.11 or approx- 
imately six to seven molecules on the 50-bp sequence. It
is difficult at this time to determine whether this is a 
reasonable stimate. Two closely spaced but not con- 
tiguous ligands could exclude MPE cleavage between 
them. Therefore, fewer molecules could appear to pro- 
vide a larger protected region. Alternatively, one could 
imagine unsymmetrical ligand binding where the tether- 
EDTA is able to oxidize the deoxyribose moiety more 
efficiently on one side of the ligand. In this case a 
somewhat larger number of bound molecules could af- 
ford a smaller protected region than expected. 
In summary, complementary-strand analyses of 
distamycin- and actinomycin-binding sites on DNA sup- 
port the asymmetric model for MPE.Fe(II) footprint- 
ing. The footprints appear to be shifted 1-2 bp to the 3' 
side on each strand and are 1 bp underprotected on the 
5'  side. With this model in hand, we expect o define 
more precisely the binding sites of small molecules on 
native DNA and to interpret more correctly single- 
strand analyses on other DNA restriction fragments. 
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